TSX News -
American Hotel Income Properties REIT LP Announces Strategic Dispositions
VANCOUVER, British Columbia, Sept. 03, 2024 (GLOBE NEWSWIRE) — American Hotel Income Properties REIT LP (“AHIP”, or the “Company”) (TSX: […]
Indonesia Energy to Present at H.C. Wainwright 26th Annual Global Investment Conference
President Frank Ingriselli Will Present Update on Development and Drilling Plans JAKARTA, INDONESIA AND DANVILLE, CA, Sept. 03, 2024 (GLOBE NEWSWIRE) […]
Kartoon Studios and LiveOne to Collaborate on Custom Audio and Video Channels
LOS ANGELES, Sept. 03, 2024 (GLOBE NEWSWIRE) — Kartoon Studios (NYSE American: TOON) and LiveOne (NASDAQ: LVO) are thrilled to […]
Ocean Power Technologies Receives Further Contract for PowerBuoy® Deployment with Naval Postgraduate School
MONROE TOWNSHIP, N.J., Sept. 03, 2024 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), […]
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
TARRYTOWN, N.Y., Sept. 03, 2024 (GLOBE NEWSWIRE) — Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Barclays Global […]
BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024
GAITHERSBURG, Md., Sept. 03, 2024 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company […]
Sysco Announces Winners From Packaging Innovation Contest
HOUSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) — Today, Sysco Corporation (NYSE:SYY), the world’s largest food distributor, announced its winners from […]
United Community Banks, Inc. and 21st Mortgage Corporation Close Sale of Manufactured Housing Loan Portfolio
GREENVILLE, S.C., Sept. 03, 2024 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (“United”) announced today the August 30th […]
BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
Authorization expands use of bezisterim in a Phase 2, placebo-controlled, multicenter trial assessing bezisterim’s impact on neurological symptoms associated with […]
Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference
SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its […]
